InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the full record of transactions filed by Marie-Paule Richard, Directrice médicale. Insider active across 1 company, notably INVENTIVA. Cumulatively, 2 filings have been recorded. Breakdown: 2 buys · 0 sell. History available since 14 December 2020. The latest transaction was disclosed on 8 December 2021 (Acquisition gratuite d'actions). Regulator: AMF. The full history is openly available.
Companies and markets linked to Marie-Paule Richard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
15,000 shares0ActionHors plateforme de négociationISIN FR00132330122021DD736965
Canonical exit: 8 Mar 2022 (T+90)
30,000 shares0ActionHors plateforme de négociationISIN FR00132330122021DD736964
Canonical exit: 14 Mar 2021 (T+90)
2 of 2 declarations
About Marie-Paule Richard
Marie-Paule Richard is the Chief Medical Officer at INVENTIVA, a biopharmaceutical company. She is responsible for medical strategy and overseeing clinical trials, contributing to innovation and the development of new treatments.
